Back to Top Skip to main content Skip to sub-navigation

DOD Officials Announce Distribution Plan for Initial COVID-19 Vaccine

Image of Mr. McCaffery speaking at a podium at the Pentagon Thomas McCaffery, the assistant secretary of defense for health affairs, briefs reporters at the Pentagon on the department’s phase, standardized and coordinated strategy for distributing and administrating COVID-19 vaccines, Dec 9, 2020. (DOD photo by Air Force Staff Sgt. Brittany Chase.)

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Regarding the initial COVID-19 vaccination rollout, Defense Department officials announced a phased and coordinated strategic plan for distributing and administering the initial COVID-19 vaccines.

Chief Pentagon spokesman, Jonathan Rath Hoffman; Assistant Secretary of Defense for Health Affairs Thomas McCaffery; and, Army Lt. Gen. Ronald J. Place, director, Defense Health Agency, described the plan at a press briefing in the Pentagon today.

"In the coming days we expect the department to receive its first allotment of the vaccine," McCaffery said, noting that DOD is expected to receive around 44,000 doses of the Pfizer vaccine in the initial phase, as early as next week, for immediate use.

An additional 44,000 doses would then be required for the follow-up dose in the two-shot series. 

Per the Centers of Disease Control and Prevention guidance, DOD will administer the first batch to health care providers and then in DOD long-term care facilities, to high-risk populations, those in critical national capability positions and finally, healthy populations, McCaffery said. 

That first batch of vaccines will be distributed to 16 locations, including three overseas. That delivery McCaffery termed a "control pilot."

The 16 sites were selected based on a sizable DOD population of high priority personnel, cold storage capability and sufficient medical personnel to administer the vaccines and monitor recipients after receiving them, he said.

As soon as the Food and Drug Administration issues an emergency use authorization, or EUA, the DOD's allocation will be pre-positioned at those 16 sites. After issuance of the EUA, the CDC's Advisory Committee on Immunization Practices, or ACIP, will meet to review the EUA, The ACIP will then vote to recommend a vaccine, how it should be disseminated and who should receive it first, and then the order of the follow-on recipients.

"We expect to have shots in arms of DOD personnel within 20 to 48 hours from the time the ACIP issues its final recommendation," McCaffery added.

As lessons from the control pilot are learned, and more vaccines are made available over time, additional locations will be added, and additional personnel, besides health care providers, will be added, he said. Eventually, all department personnel will be eligible to be vaccinated: active and selective reserve components, including the National Guard, family members, retirees, DOD civilians and select DOD contractors.

"Future allocations of the COVID-19 vaccine will focus on vaccinating priority populations quickly and safely, while simultaneously refining the intricate planning for the delivery of larger volumes of vaccine in future waves," McCaffery said.

The department will prioritize DOD personnel to receive the vaccine based on the CDC guidance and on the department's COVID Task Force assessment of unique mission requirements, he said.

"The department's priorities are protecting our service members, our civilian employees and families and safeguarding our national security capabilities in supporting the whole of government response to the COVID-19 pandemic," said McCaffery. 

The department's plan to distribute the vaccine DOD-wide was developed in collaboration with Operation Warp Speed and CDC guidance, he said.

Place encouraged DOD personnel to take the vaccine when it becomes available, because as for now, it is voluntary.

"While we await final approval from the FDA, the preliminary data on the safety and effectiveness of the two vaccine candidates is highly encouraging and we're recommending that everyone take the vaccine when it becomes available to protect yourselves, your families, your shipmates, your wingman your battle buddies and your communities," Place said. 

The other vaccine he spoke of is made by Moderna and is expected to be made available to the department in the near future.

"As with most vaccines, some people may experience small adverse effects such as arm soreness, fatigue, even a fever," Place said. "The department will be fully transparent about any adverse effects that are reported and will share this information with the CDC."

Hoffman added his agreement with Place: "Our goal is to be transparent with the force about what is happening, and to encourage our personnel to use the vaccine."

You also may be interested in...

COVID-19: Know what the terms mean

Article
3/10/2020
Soldiers stationed on U.S. Army Garrison Casey conduct pre-screening processes on individuals awaiting entry to the base, USAG-Casey, Dongducheon, Republic of Korea, Feb. 26, 2020. Additional screening measures of a verbal questionnaire and temperature check are in response to the heighted awareness of Coronavirus (COVID-19) following a surge in cases throughout the Republic of Korea and are meant to help control the spread of COVID-19 and to protect the force. (U.S. Army photo by Sgt. Amber I. Smith)

Learning the language can help you stay safe

Recommended Content:

Coronavirus | Public Health | Combat Support | Coronavirus

Coronavirus: What you need to know

Article
3/6/2020
A Guardsmen with the 341st Military Intelligence Battalion conducts translation work on a safety message regarding the best practices for avoiding the novel coronavirus for the Washington Department of Health on Feb. 9, 2020 at the Information Operations Readiness Center, Joint Base Lewis-McChord, Wash. (Courtesy Photo)

Although news stories and images contain many reports of people wearing surgical masks to ward off the virus, that's not recommended

Recommended Content:

Global Health Engagement | Public Health | Coronavirus | Coronavirus

DoD makes plans to combat Coronavirus

Article
3/4/2020
Defense Secretary Dr. Mark T. Esper and Army Gen. Mark A. Milley, chairman of the Joint Chiefs of Staff, speak to reporters at the Pentagon, March 2, 2020. (DoD photo Lisa Ferdinando)

The number one priority remains to protect our forces and their families

Recommended Content:

Coronavirus | Public Health | Combat Support | Coronavirus

MHS prepared to support interagency coronavirus response

Article
2/6/2020
Airmen assist one another in donning their personal protective equipment, while on-board an Air Force C-17 Globemaster III during transportation isolation system training at Joint Base Charleston, South Carolina. Engineered and implemented after the Ebola virus outbreak in 2014, the TIS is an enclosure the Department of Defense can use to safely transport patients with diseases like novel coronavirus. (U.S. Air Force photo by Senior Airman Cody R. Miller)

From R&D to force health protection, MHS protects DoD personnel and families

Recommended Content:

Global Health Engagement | Public Health | Coronavirus | Coronavirus

DoD releases guidance to protect forces from novel coronavirus

Article
1/31/2020
The novel coronavirus is a variant of other coronaviruses, such as this colorized transmission electron micrograph of Middle East respiratory syndrome (MERS) virus particles (blue) found near the periphery of an infected VERO E6 cell (yellow). Image captured and color-enhanced at the NIAID Integrated Research Facility in Fort Detrick, Maryland. (Photo by NIAID)

Basic infection controls offer best defense against illness

Recommended Content:

Global Health Engagement | Public Health | Coronavirus | Coronavirus

Coronavirus: What providers, patients should know

Article
1/24/2020
Many forms of coronavirus exist among both humans and animals, but this new strain’s has caused alarm. (CDC graphic)

What to do now that virus has appeared in U.S.

Recommended Content:

Global Health Engagement | Public Health | Coronavirus | Coronavirus

MHS GENESIS Patient Portal Fact Sheet

Fact Sheet
7/30/2019

This fact sheet describes the MHS GENESIS Patient Portal.

Recommended Content:

COVID-19 Vaccine Toolkit | MHS GENESIS Toolkit
<< < ... 41 42 43 > >> 
Showing results 631 - 637 Page 43 of 43

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.